A pooled analysis showed that the presence of PIK3CA mutations is a negative prognostic factor (pooled overall survival [OS], disease‐free survival [DFS], and progression‐free survival [PFS]) in breast cancer.13 The gene discussed is PIK3CA; the disease is breast carcinoma.